Drug Type AAV based gene therapy |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization NeuExCell Therapeutics, Inc.Startup |
Active Organization NeuExCell Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Disease | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Digestive System Disorders | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Infectious Diseases | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Inflammation | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Neoplasms | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Nervous System Diseases | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Skin and Musculoskeletal Diseases | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Urogenital Diseases | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Vascular Diseases | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |
Wounds and Injuries | Discovery | - | NeuExCell Therapeutics, Inc.Startup | 07 Apr 2022 |